In one of the first and largest published evaluations of the use of Pre-exposure Prophylaxis (PrEP) to prevent HIV infection in a clinical practice setting, researchers at Kaiser Permanente found no new HIV infections among patients during more than 2.5 years of observation. The study was the first done outside of clinical trials and demonstration sites and suggests that PrEP may prevent new HIV infections in a high-risk setting. Read more about the study here.
Large Study of PrEP Use in Clinical Practice Shows No New HIV Infections
Sep 03, 2015 | Alyssa Kitlas
Related Posts
- Adverse Childhood Experiences (ACEs)
- Behavioral Health
- Community Health
- Injury and Violence Prevention
Seeking LHD Participants for an Intersectional Data...
With support from the Centers for Disease Control and Prevention, NACCHO is...
Mar 26, 2024 | Camille Adams
Seeking LHD Participants for an Intersectional Data...
- Mobilizing for Action through Planning and Partnerships (MAPP)
- Performance Improvement
- Workforce Development
Register to Attend a Mobilizing for Action through...
Registration is now open for NACCHO’s in-person Mobilizing for Action through...
Mar 23, 2024 | Andrea Grenadier